D
Duk-Woo Park
Researcher at University of Ulsan
Publications - 421
Citations - 15164
Duk-Woo Park is an academic researcher from University of Ulsan. The author has contributed to research in topics: Percutaneous coronary intervention & Myocardial infarction. The author has an hindex of 60, co-authored 355 publications receiving 13032 citations.
Papers
More filters
Journal ArticleDOI
Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease
Ki Bae Seung,Duk-Woo Park,Young-Hak Kim,Seung-Whan Lee,Cheol Whan Lee,Myeong Ki Hong,Seong-Wook Park,Sung-Cheol Yun,Hyeon-Cheol Gwon,Myung Ho Jeong,Yangsoo Jang,Hyo-Soo Kim,Pum Joon Kim,In Whan Seong,Hun Sik Park,Taehoon Ahn,In-Ho Chae,Seung-Jea Tahk,Wook-Sung Chung,Seung-Jung Park +19 more
TL;DR: In a cohort of patients with unprotected left main coronary artery disease, there was no significant difference in rates of death or of the composite end point of death, Q-wave myocardial infarction, or stroke between patients receiving stents and those undergoing CABG, but stenting, even with drug-eluting stents, was associated with higher rates of target-vessel revascularization than was CABGs.
Journal ArticleDOI
Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up.
Duk-Woo Park,Seong Wook Park,Kyoung Ha Park,Bong Ki Lee,Young-Hak Kim,Cheol Whan Lee,Myeong Ki Hong,Jae Joong Kim,Seung-Jung Park +8 more
TL;DR: Stent thrombosis occurred in 0.8% after DES implantation during long-term follow-up, similar to that for bare metal stents, and independent predictors were premature antiplatelet therapy interruption, primary stenting in acute myocardial infarction, and total stent length.
Journal ArticleDOI
Impact of Intravascular Ultrasound Guidance on Long-Term Mortality in Stenting for Unprotected Left Main Coronary Artery Stenosis
Seung-Jung Park,Young-Hak Kim,Duk-Woo Park,Seung-Whan Lee,Won Kim,Jon Suh,Sung Cheol Yun,Cheol Whan Lee,Myeong Ki Hong,Jae-Hwan Lee,Seong Wook Park +10 more
TL;DR: Elective stenting with IVUS guidance, especially in the placement of drug-eluting stent, may reduce the long-term mortality rate for unprotected left main coronary artery stenosis when compared with conventional angiography guidance.
Journal ArticleDOI
Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents
Seung-Jung Park,Duk-Woo Park,Young-Hak Kim,Soo Jin Kang,Seung-Whan Lee,Cheol Whan Lee,Ki Hoon Han,Seong Wook Park,Sung Cheol Yun,Sang-Gon Lee,Seung-Woon Rha,In Whan Seong,Myung Ho Jeong,Seung Ho Hur,Nae Hee Lee,Junghan Yoon,Joo Young Yang,Bong Ki Lee,Young Jin Choi,Wook Sung Chung,Do-Sun Lim,Sang Sig Cheong,Kee Sik Kim,Jei Keon Chae,Deuk Young Nah,Doo-Soo Jeon,Ki Bae Seung,Jae-Sik Jang,Hun Sik Park,Keun Seok Lee +29 more
TL;DR: The use of dual antiplatelet therapy for a period longer than 12 months in patients who had received drug-eluting stents was not significantly more effective than aspirin monotherapy in reducing the rate of myocardial infarction or death from cardiac causes.
Journal ArticleDOI
Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease
Seung-Jung Park,Jung-Min Ahn,Young-Hak Kim,Duk-Woo Park,Sung Cheol Yun,Jong-Young Lee,Soo Jin Kang,Seung-Whan Lee,Cheol Whan Lee,Seong Wook Park,Suk Jung Choo,Cheol Hyun Chung,Jae Won Lee,David J. Cohen,Alan C. Yeung,Seung Ho Hur,Ki Bae Seung,Tae Hoon Ahn,Hyuck Moon Kwon,Do Sun Lim,Seung-Woon Rha,Myung Ho Jeong,Bong Ki Lee,Damras Tresukosol,Guo Sheng Fu,Tiong Kiam Ong +25 more
TL;DR: Among patients with multivessel coronary artery disease, the rate of major adverse cardiovascular events was higher among those who had undergone PCI with the use of everolimus-eluting stents than among thoseWho had undergone CABG.